Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies

Cost Effectiveness ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Effectiveness Analysis ◽

Epidermal Growth ◽

Predictive Assay

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-016-3958-x ◽

2016 ◽

Vol 159 (3) ◽

pp. 565-573 ◽

Cited By ~ 10

Author(s):

Quang A. Le ◽

Yuna H. Bae ◽

Jenny H. Kang

Keyword(s):

Breast Cancer ◽

Cost Effectiveness ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Effectiveness Analysis ◽

Cost‑effectiveness analysis of different sequences of osimertinib administration for epidermal growth factor receptor‑mutated non‑small‑cell lung cancer

Experimental and Therapeutic Medicine ◽

10.3892/etm.2021.9774 ◽

2021 ◽

Vol 21 (4) ◽

Author(s):

Wenqian Li ◽

Lei Qian ◽

Wei Li ◽

Xiao Chen ◽

Hua He ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Effectiveness Analysis ◽

Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients

Indian Journal of Surgery ◽

10.1007/s12262-020-02380-y ◽

2020 ◽

Author(s):

Adarsh Verma ◽

Amrita Ghosh Kar ◽

Ram Niwas Meena ◽

S. C. U. Patne ◽

Shashi Prakash Mishra ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Chemotherapy ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Before And After ◽

Benefit of Gonadotropin-releasing Hormone (GnRH) agonist administration with Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2-Negative subtype for young breast cancer patients

The Breast ◽

10.1016/s0960-9776(17)30344-2 ◽

2017 ◽

Vol 32 ◽

pp. S108

Author(s):

T.I. Yoon ◽

S.B. Lee ◽

G. Sohn ◽

B.S. Ko ◽

J.W. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Gonadotropin Releasing Hormone ◽

Breast Cancer Patients ◽

Hormone Receptor Positive ◽

Epidermal Growth ◽

Young Breast Cancer

Abstract P3-06-10: All-cause resource use among elderly breast cancer patients by receipt of human epidermal growth factor receptor 2-targeted therapy: An analysis of US national data 2006-2009

10.1158/0008-5472.sabcs13-p3-06-10 ◽

2013 ◽

Author(s):

Y Hao ◽

K Lang ◽

H Huang ◽

V Federico ◽

J Menzin

Keyword(s):

Breast Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Resource Use ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

National Data ◽

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs17-p3-04-03 ◽

2018 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Efficacy, safety and administration timing of trastuzumab in human epidermal growth factor receptor 2 positive breast cancer patients: A meta-analysis

Experimental and Therapeutic Medicine ◽

10.3892/etm.2016.3095 ◽

2016 ◽

Vol 11 (5) ◽

pp. 1721-1733 ◽

Cited By ~ 4

Author(s):

YUAN-YUAN CHEN ◽

LIN-WEI WANG ◽

FANG-FANG CHEN ◽

BI-BO WU ◽

BIN XIONG

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Epidermal Growth ◽

Administration Timing ◽

Positive Breast Cancer

Expression Analyses of Epidermal Growth Factor Receptor and HER-2/neu: No Advantage of Prediction of Recurrence or Survival in Breast Cancer Patients

Oncology ◽

10.1159/000227618 ◽

1996 ◽

Vol 53 (6) ◽

pp. 441-447 ◽

Cited By ~ 16

Author(s):

Matthias W. Beckmann ◽

Dieter Niederacher ◽

Gero Massenkeil ◽

Boris Tutschek ◽

Andreas Beckmann ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Her 2 ◽

Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12514 ◽

2016 ◽

Vol 12 (4) ◽

pp. 369-379 ◽

Cited By ~ 8

Author(s):

Nirmala Pathmanathan ◽

Jing‐shu Geng ◽

Wencai Li ◽

Xiu Nie ◽

Januario Veloso ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Breast Cancer Patients ◽

Human Epidermal Growth Factor ◽